BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3180111)

  • 1. Enhancement of the thermic effect of food by d-fenfluramine.
    Levitsky DA; Stallone D
    Clin Neuropharmacol; 1988; 11 Suppl 1():S90-2. PubMed ID: 3180111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic fenfluramine treatment: effects on body weight, food intake and energy expenditure.
    Stallone DD; Levitsky DA
    Int J Obes Relat Metab Disord; 1994 Oct; 18(10):679-85. PubMed ID: 7866463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic consequences of fenfluramine for the control of body weight.
    Levitsky DA; Troiano R
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):167S-172S. PubMed ID: 1728828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the thermic effect of food by fenfluramine.
    Levitsky DA; Schuster JA; Stallone D; Strupp BJ
    Int J Obes; 1986; 10(3):169-73. PubMed ID: 3759326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.
    Vickers SP; Benwell KR; Porter RH; Bickerdike MJ; Kennett GA; Dourish CT
    Br J Pharmacol; 2000 Jul; 130(6):1305-14. PubMed ID: 10903970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permanent administration of d-fenfluramine in rats: paradoxical effects.
    Rozen R; Fumeron F; Betoulle D; Baigts F; Mandenoff A; Fricker J; Apfelbaum M
    Clin Neuropharmacol; 1988; 11 Suppl 1():S105-12. PubMed ID: 3052811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute, subacute and chronic effects of central neuropeptide Y on energy balance in rats.
    Székely M; Pétervári E; Pákai E; Hummel Z; Szelényi Z
    Neuropeptides; 2005 Apr; 39(2):103-15. PubMed ID: 15752544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenfluramine treatment in female rats accelerates the weight loss associated with activity-based anorexia.
    Atchley DP; Eckel LA
    Pharmacol Biochem Behav; 2005 Feb; 80(2):273-9. PubMed ID: 15680180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
    Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
    Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between metabolic and behavioral effects of dexfenfluramine treatment.
    Even P; Coulaud H; Aucouturier JL; Nicolaidis S
    Clin Neuropharmacol; 1988; 11 Suppl 1():S93-6. PubMed ID: 3180112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats.
    Larsen PJ; Vrang N; Petersen PC; Kristensen P
    Obes Res; 2000 Nov; 8(8):590-6. PubMed ID: 11156435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the 5-hydroxytryptamine agonist D,L-fenfluramine on energy balance in rats: influence of gender.
    Dagnault A; Deshaies Y; Richard D
    Int J Obes Relat Metab Disord; 1993 Jul; 17(7):367-73. PubMed ID: 8395471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raw vegetable food containing high cyclo (his-pro) improved insulin sensitivity and body weight control.
    Song MK; Rosenthal MJ; Song AM; Yang H; Ao Y; Yamaguchi DT
    Metabolism; 2005 Nov; 54(11):1480-9. PubMed ID: 16253637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone-induced suppression of food intake is potentiated by neonatal administration of monosodium glutamate to mice.
    Dawson R
    Neurobehav Toxicol Teratol; 1983; 5(5):523-6. PubMed ID: 6664410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dl-fenfluramine on thermic effect of food in humans.
    Troiano RP; Levitsky DA; Kalkwarf HJ
    Int J Obes; 1990 Aug; 14(8):647-55. PubMed ID: 2228399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that may effect the reduction of hunger and body weight following d-fenfluramine administration.
    Campbell DB; Gordon BH; Ings RM; Richards R; Taylor DW
    Clin Neuropharmacol; 1988; 11 Suppl 1():S160-72. PubMed ID: 3052814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of triethyltin on ingestive behavior at ad lib, reduced, and recovered body weight.
    DeHaven DL; Wayner MJ; Barone FC; Evans SM
    Neurobehav Toxicol Teratol; 1982; 4(2):217-23. PubMed ID: 6123956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexfenfluramine and body weight regulation: experimental study with hoarding behavior.
    Fantino M; Boucher H; Faïon F; Mathiot P
    Clin Neuropharmacol; 1988; 11 Suppl 1():S97-104. PubMed ID: 3180113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel antiobesic HMR1426 reduces food intake without affecting energy expenditure in rats.
    Ortmann S; Kampe J; Gossel M; Bickel M; Geisen K; Jähne G; Lang HJ; Klaus S
    Obes Res; 2004 Aug; 12(8):1290-7. PubMed ID: 15340112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent, chronic fenfluramine administration to rats repeatedly suppresses food intake despite substantial brain serotonin reductions.
    Choi S; Jonak EM; Simpson L; Patil V; Fernstrom JD
    Brain Res; 2002 Feb; 928(1-2):30-9. PubMed ID: 11844469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.